Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs aimed toward growing the horizons of cytokine-based immunotherapy, specifically for cancers where cure solutions remain limited. Utilize the links below to learn extra about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline We https://financefeeds.com/21x-taps-philip-filhol-for-business-development-ahead-of-exchange-launch/